Department Of Microbiology 2
51. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
52. Biocontrol strategies in agricultural green development and soil health management to achieve sustainable growth in agriculture
53. Global, regional, and national stillbirths at 20 weeks gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
54. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
55. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
56. Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
57. Eubiotics Improve Gut Health and Overall Production in Animals by Reducing Pathogenic Bacteria
58. Electroactivity of weak electricigen Bacillus subtilis biofilms in solution containing deep eutectic solvent components
59. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
60. Managing penicillin resistant pneumococcal meningitis: an international id-iri study
61. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
62. Marburg virus disease in Equatorial Guinea: The need for one health approach
63. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
64. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
65. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
66. Global organic acids production and their industrial applications
67. Combating the menace of antimicrobial resistance in Africa: a review on stewardship, surveillance and diagnostic strategies
68. Combating the menace of antimicrobial resistance in Africa: a review on stewardship, surveillance and diagnostic strategies
69. Diphtheria outbreak in Nigeria: What do we know so far?
70. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
71. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
72. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
73. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
74. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
75. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
76. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
77. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
78. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
79. Immune System Response after Immobilization Stress in the Background of Ionizing Radiation
80. Biosynthesized silver nanoparticles and miR34a mimics mediated activation of death receptor in MCF-7 human breast cancer cell lines
81. Public health risks associated with antibiotic residues in poultry food products
82. Characterization and statistical optimization of biosurfactant production using Bacillus subtilis isolated from automotive oil-contaminated soil in Yola, Nigeria
83. Correction: Genistein as a regulator of signaling pathways and microRNAs in different types of cancers (Cancer Cell International, (2021), 21, 1, (388), 10.1186/s12935-021-02091-8)
84. Genistein as a regulator of signaling pathways and microRNAs in different types of cancers
85. Comparative Phytochemical, Colloidal, and Antioxidant Profiling of Artemisia albida, Artemisia leucodes, and Artemisia scopaeformis: Potentials for Cosmeceutical and Nutraceutical Applications
86. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
87. Effects of co-inoculation with Bradyrhizobium and Trichoderma harzianum on soybean nitrogen nutrition and multispectral traits
88. An Improved Method and Device for Nucleic Acid Isolation Using a High-Salt Gel Electroelution Trap
89. Electroelution Into a Salt Trap: Reviving an Old-School Approach to DNA Purification
90. Isolation of High-Molecular-Weight DNA for Long-Read Sequencing Using a High-Salt Gel Electroelution Trap
91. Epidemiological characteristics and financial losses due to avian aspergillosis in households in the Almaty region, Republic of Kazakhstan
92. Antitumor potential of silver nanoparticles against lung cancer: current trends, scope and relevance
93. A second update on mapping the human genetic architecture of COVID-19
94. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
95. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
96. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
97. Thiadiazole and Thiazole Derivatives as Potential Antimicrobial Agents
98. Genome-guided approaches and evaluation of the strategies to influence bioprocessing assisted morphological engineering of Streptomyces cell factories
99. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
100. Epizootological monitoring of some bacterial infectious diseases of animals on the territory of the Republic of Kazakhstan
1 2 3 4 6